DOCSLIB.ORG

Draft Genome of Thermomonospora Sp. CIT 1 (Thermomonosporaceae) and in Silico Evidence of Its Functional Role in Filter Cake Biomass Deconstruction

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
Draft Genome of Thermomonospora Sp. CIT 1 (Thermomonosporaceae) and in Silico Evidence of Its Functional Role in Filter Cake Biomass Deconstruction 1 Genetics and Molecular Biology Suplementary material to: Draft genome of Thermomonospora sp. CIT 1 (Thermomonosporaceae) and in silico evidence of its functional role in filter cake biomass deconstruction Table S3 - Identifications of enzymes with activity on carbohydrate structures present in the draft genome CIT 1 recovered from metagenomic sequencing of filter cake. Predictions were performed with dbCAN online, following for blastp confirmation against the non-redundant NCBI protein database of the occurrence of predicted protein-like sequence deposition. Search results for dbCAN conserved domains BLASTP RESULTS ORF CAZy QUERY E- IDENTIT LENGTH ID CAZy ENZYME NAME (NCBI) ACCESSION FAMILY COVER VALUE Y 747 AA2.hmm peroxidase (EC 1.11.1.-) catalase/peroxidase HPI 100 0.00E+00 100 WP_012852289 glucose-methanol-choline 786 AA3.hmm glucose-methanol-choline (GMC) 100 0.00E+00 100 ACY97563 oxidoreductase mycofactocin system GMC family 520 AA3.hmm glucose-methanol-choline (GMC) 99 0.00E+00 99 WP_012852714 oxidoreductase MftG 582 AA3.hmm glucose-methanol-choline (GMC) GMC family oxidoreductase 100 0.00E+00 99 WP_012854558 531 AA3_2.hmm glucose-methanol-choline (GMC) choline dehydrogenase 100 0.00E+00 100 WP_012854223 533 AA4.hmm vanillyl-alcohol oxidase (EC 1.1.3.38) FAD-binding oxidoreductase 99 0.00E+00 99 WP_012852156 NAD(P)H:quinone oxidoreductase 4.00E- 209 AA6.hmm 1,4-benzoquinone reductase (EC. 1.6.5.6) 100 100 WP_012850533 type IV 152 187 AA6.hmm 1,4-benzoquinone reductase (EC. 1.6.5.6) NAD(P)H-dependent oxidoreductase 100 9.00E-86 69 WP_067443322 6.00E- 152 AA6.hmm 1,4-benzoquinone reductase (EC. 1.6.5.6) flavodoxin 99 100 WP_012853676 104 3.00E- 178 AA6.hmm 1,4-benzoquinone reductase (EC. 1.6.5.6) NADPH-dependent oxidoreductase 100 99 WP_012855187 124 457 AA7.hmm 1- FAD-binding oxidoreductase 100 0.00E+00 100 WP_012850500 441 AA7.hmm - FAD-linked oxidoreductase 100 0.00E+00 100 WP_012852047 FAD linked oxidase domain- 378 AA7.hmm - 100 0.00E+00 99 WP_012852317 containing protein 459 AA7.hmm - FAD-binding oxidoreductase 100 0.00E+00 99 WP_012853068 2 Search results for dbCAN conserved domains BLASTP RESULTS ORF CAZy QUERY E- IDENTIT LENGTH ID CAZy ENZYME NAME (NCBI) ACCESSION FAMILY COVER VALUE Y 502 AA7.hmm - FAD-binding oxidoreductase 92 0.00E+00 99 WP_012853288 482 AA7.hmm - FAD-binding oxidoreductase 100 0.00E+00 99 WP_012853594 411 AA7.hmm - FAD-binding oxidoreductase 100 0.00E+00 99 WP_012853595 lytic polysaccharide monooxygenases 8.00E- 188 AA10.hmm chitin-binding domain 3 protein 100 90 ACZ00089 (LPMOs) 109 2.00E- 159 CBM2.hmm CBM2 cellulose-binding family II 100 100 WP_012853764 109 447 CBM2.hmm CBM2 cellulose-binding family II 99 0.00E+00 99 ACY99074 335 CBM13.hmm - hypothetical protein Tcur_3315 100 0.00E+00 99 ACY98853 coagulation factor 5/8 type domain 1430 CBM32.hmm - 100 0.00E+00 99 ACY99521 protein 532 CBM32.hmm - phosphopeptide-binding protein 100 0.00E+00 100 WP_012855260 498 CBM35.hmm CBM35+GH43 glycoside hydrolase family 43 100 0.00E+00 99 WP_012851007 918 CBM44.hmm - PKD domain-containing protein 100 0.00E+00 99 WP_012851385 701 CBM48.hmm - glycogen debranching enzyme GlgX 100 0.00E+00 100 WP_012852133 736 CBM48.hmm - 1,4-alpha-glucan-branching protein 100 0.00E+00 99 WP_012853921 680 CBM48.hmm - glycogen debranching protein 100 0.00E+00 99 WP_012854434 280 CE1.hmm esterase esterase 100 0.00E+00 99 WP_012851583 288 CE1.hmm esterase esterase 100 0.00E+00 100 WP_012850408 284 CE1.hmm esterase alpha/beta hydrolase fold protein 100 0.00E+00 99 ACY97135 347 CE1.hmm esterase alpha/beta hydrolase 91 0.00E+00 99 WP_012852003 362 CE1.hmm - hypothetical protein 100 0.00E+00 99 WP_052305466 9.00E- 309 CE1.hmm esterase alpha/beta hydrolase fold protein 72 99 WP_012852600 154 278 CE1.hmm cinnamoyl esterase (EC 3.1.1.-) putative lipoprotein 100 0.00E+00 99 WP_012854167 292 CE1.hmm cinnamoyl esterase (EC 3.1.1.-) lipase 100 0.00E+00 99 WP_012850775 263 CE1.hmm esterase alpha/beta hydrolase 100 0.00E+00 100 WP_012854209 3 Search results for dbCAN conserved domains BLASTP RESULTS ORF CAZy QUERY E- IDENTIT LENGTH ID CAZy ENZYME NAME (NCBI) ACCESSION FAMILY COVER VALUE Y 364 CE1.hmm esterase alpha/beta hydrolase 100 0.00E+00 100 WP_012854576 374 CE1.hmm esterase putative esterase 100 0.00E+00 100 ACY96221 SGNH/GDSL hydrolase family 253 CE2.hmm - 100 0.00E+00 99 WP_012851045 protein 343 CE3.hmm - GDSL family lipase 100 0.00E+00 100 WP_012851417 267 CE4.hmm - polysaccharide deacetylase 100 0.00E+00 99 WP_012851516 341 CE4.hmm - polysaccharide deacetylase 100 0.00E+00 99 ACY97622 375 CE4.hmm - polysaccharide deacetylase 100 0.00E+00 98 WP_012853180 polysaccharide deacetylase family 285 CE4.hmm - 100 0.00E+00 100 WP_012853293 protein 264 CE4.hmm - polysaccharide deacetylase 100 0.00E+00 99 WP_012853908 4.00E- 234 CE4.hmm - polysaccharide deacetylase 100 100 ACZ00196 168 polysaccharide deacetylase family 275 CE4.hmm - 100 0.00E+00 99 WP_012855020 protein 5.00E- 235 CE5.hmm cutinase (EC 3.1.1.74) cutinase family protein 100 99 WP_012851874 164 4.00E- 241 CE5.hmm cutinase (EC 3.1.1.74) cutinase 100 99 ACY97091 175 6.00E- 176 CE5.hmm cutinase (EC 3.1.1.74) cutinase family protein 100 99 WP_012851879 123 N-acetylglucosamine 6-phosphate deacetylase N-acetylglucosamine-6-phosphate 410 CE9.hmm 100 0.00E+00 99 WP_012854344 (EC 3.5.1.25) deacetylase Alpha/beta hydrolase fold-3 domain 349 CE10.hmm esterase 100 0.00E+00 100 ACY96637 protein 335 CE10.hmm esterase alpha/beta hydrolase 100 0.00E+00 100 WP_012851463 692 CE10.hmm - S9 family peptidase 100 0.00E+00 99 WP_012851498 703 CE10.hmm - S9 family peptidase 100 0.00E+00 100 WP_012851705 593 CE10.hmm cinnamoyl esterase (EC 3.1.1.-) Esterase/lipase-like protein 100 0.00E+00 99 ACY97597 317 CE10.hmm esterase alpha/beta hydrolase 100 0.00E+00 100 WP_012852810 4 Search results for dbCAN conserved domains BLASTP RESULTS ORF CAZy QUERY E- IDENTIT LENGTH ID CAZy ENZYME NAME (NCBI) ACCESSION FAMILY COVER VALUE Y 323 CE10.hmm esterase alpha/beta hydrolase 100 0.00E+00 100 WP_012852854 489 CE10.hmm - peptidase S15 100 0.00E+00 99 WP_012852916 546 CE10.hmm carboxyl esterase (EC 3.1.1.3) carboxylesterase family protein 100 0.00E+00 99 WP_012850644 alpha/beta hydrolase fold-3 domain- 2.00E- 234 CE10.hmm esterase 100 100 WP_012853073 containing protein 158 668 CE10.hmm - S9 family peptidase 100 0.00E+00 100 WP_012853613 343 CE10.hmm esterase alpha/beta hydrolase 100 0.00E+00 99 WP_012854310 364 CE10.hmm esterase alpha/beta hydrolase 100 0.00E+00 100 WP_012854576 362 CE10.hmm esterase alpha/beta hydrolase 99 0.00E+00 99 WP_083789919 587 CE10.hmm - S9 family peptidase 100 0.00E+00 99 WP_012855196 303 CE14.hmm mycothiol S-conjugate amidase (EC 3.5.1.-) mycothiol conjugate amidase Mca 100 0.00E+00 100 ACY96652 N-acetyl-1-D-myo-inosityl-2-amino-2-deoxy- 1D-myo-inositol 2-acetamido-2- 297 CE14.hmm α-D-glucopyranoside deacetylase (EC deoxy-alpha-D-glucopyranoside 100 0.00E+00 100 WP_012851500 3.5.1.89) deacetylase N-acetyl-1-D-myo-inosityl-2-amino-2-deoxy- 271 CE14.hmm α-D-glucopyranoside deacetylase (EC GlcNAc-PI de-N-acetylase 100 0.00E+00 100 WP_041441415 3.5.1.89) 482 GH1.hmm β-glucosidase (EC 3.2.1.21) beta-glucosidase 100 0.00E+00 100 WP_012852091 471 GH1.hmm β-glucosidase (EC 3.2.1.21) beta-glucosidase 100 0.00E+00 100 WP_012852534 447 GH1.hmm β-glucosidase (EC 3.2.1.21) beta-glucosidase 100 0.00E+00 99 WP_012855073 glycoside hydrolase family 3 domain- 543 GH3.hmm - 100 0.00E+00 100 WP_012854338 containing protein 427 GH4.hmm - glycoside hydrolase family 4 100 0.00E+00 99 WP_012854171 626 GH5_43.hmm endoglycoceramidase (EC 3.2.1.123) endoglycosylceramidase 98 0.00E+00 99 WP_012851730 409 GH6.hmm - glycoside hydrolase family 6 100 0.00E+00 99 WP_012852096 701 GH13_11.hmm - glycogen debranching enzyme GlgX 100 0.00E+00 100 WP_012852133 680 GH13_11.hmm - glycogen debranching protein 100 0.00E+00 99 WP_012854434 613 GH13_16.hmm - maltose alpha-D-glucosyltransferase 100 0.00E+00 99 WP_083790013 5 Search results for dbCAN conserved domains BLASTP RESULTS ORF CAZy QUERY E- IDENTIT LENGTH ID CAZy ENZYME NAME (NCBI) ACCESSION FAMILY COVER VALUE Y α-1,4-glucan: phosphate α-maltosyltransferase alpha-1,4-glucan-maltose-1-phosphate 661 GH13_3.hmm 100 0.00E+00 99 WP_012853902 (EC 2.4.99.16) maltosyltransferase 550 GH13_30.hmm α-amylase (EC 3.2.1.1) alpha-amylase 100 0.00E+00 99 WP_012852097 736 GH13_9.hmm branching enzyme (EC 2.4.1.18) 1,4-alpha-glucan-branching protein 100 0.00E+00 99 WP_012853921 629 GH15.hmm - glycoside hydrolase family 15 protein 100 0.00E+00 100 WP_012853541 484 GH15.hmm - glycoside hydrolase family 15 100 0.00E+00 100 WP_012854532 272 GH23.hmm - hypothetical protein 100 0.00E+00 100 WP_012851447 352 GH23.hmm - NLP/P60 protein 99 0.00E+00 100 WP_012851472 peptidoglycan lyase (EC 4.2.2.n1) also known lytic transglycosylase domain- 378 GH23.hmm in the literature as peptidoglycan lytic 100 0.00E+00 99 WP_012852049 containing protein transglycosylase 8.00E- 246 GH23.hmm - hypothetical protein 100 99 WP_012852903 180 peptidoglycan lyase (EC 4.2.2.n1) also known transglycosylase domain-containing 266 GH23.hmm in the literature as peptidoglycan lytic 100 0.00E+00 100 WP_012851352 protein transglycosylase 297 GH25.hmm - glycoside hydrolase family 25 100 0.00E+00 100 WP_012852705 371 GH25.hmm - glycoside hydrolase family 25 100 0.00E+00 99 WP_012850936 334 GH26.hmm β-mannanase (EC 3.2.1.78) beta-mannanase-like protein 100 0.00E+00 99 WP_012854497 335 GH26.hmm - hypothetical protein 100 0.00E+00 100 WP_012851356 506 GH26.hmm - hypothetical protein 100 0.00E+00 100 WP_012851387 465 GH30.hmm -
Load more

Recommended publications
  • Bacteria Belonging to Pseudomonas Typographi Sp. Nov. from the Bark Beetle Ips Typographus Have Genomic Potential to Aid in the Host Ecology
    insects Article Bacteria Belonging to Pseudomonas typographi sp. nov. from the Bark Beetle Ips typographus Have Genomic Potential to Aid in the Host Ecology Ezequiel Peral-Aranega 1,2 , Zaki Saati-Santamaría 1,2 , Miroslav Kolaˇrik 3,4, Raúl Rivas 1,2,5 and Paula García-Fraile 1,2,4,5,* 1 Microbiology and Genetics Department, University of Salamanca, 37007 Salamanca, Spain; [email protected] (E.P.-A.); [email protected] (Z.S.-S.); [email protected] (R.R.) 2 Spanish-Portuguese Institute for Agricultural Research (CIALE), 37185 Salamanca, Spain 3 Department of Botany, Faculty of Science, Charles University, Benátská 2, 128 01 Prague, Czech Republic; [email protected] 4 Laboratory of Fungal Genetics and Metabolism, Institute of Microbiology of the Academy of Sciences of the Czech Republic, 142 20 Prague, Czech Republic 5 Associated Research Unit of Plant-Microorganism Interaction, University of Salamanca-IRNASA-CSIC, 37008 Salamanca, Spain * Correspondence: [email protected] Received: 4 July 2020; Accepted: 1 September 2020; Published: 3 September 2020 Simple Summary: European Bark Beetle (Ips typographus) is a pest that affects dead and weakened spruce trees. Under certain environmental conditions, it has massive outbreaks, resulting in attacks of healthy trees, becoming a forest pest. It has been proposed that the bark beetle’s microbiome plays a key role in the insect’s ecology, providing nutrients, inhibiting pathogens, and degrading tree defense compounds, among other probable traits. During a study of bacterial associates from I. typographus, we isolated three strains identified as Pseudomonas from different beetle life stages. In this work, we aimed to reveal the taxonomic status of these bacterial strains and to sequence and annotate their genomes to mine possible traits related to a role within the bark beetle holobiont.
    [Show full text]
  • Analysis of Carbohydrates and Glycoconjugates by Matrix-Assisted Laser Desorption/Ionization Mass Spectrometry: an Update for 2011–2012
    ANALYSIS OF CARBOHYDRATES AND GLYCOCONJUGATES BY MATRIX-ASSISTED LASER DESORPTION/IONIZATION MASS SPECTROMETRY: AN UPDATE FOR 2011–2012 David J. Harvey* Department of Biochemistry, Oxford Glycobiology Institute, University of Oxford, Oxford OX1 3QU, UK Received 19 June 2014; accepted 15 January 2015 Published online in Wiley Online Library (wileyonlinelibrary.com). DOI 10.1002/mas.21471 This review is the seventh update of the original article published text. As the review is designed to complement the earlier work, in 1999 on the application of MALDI mass spectrometry to the structural formulae, etc. that were presented earlier are not analysis of carbohydrates and glycoconjugates and brings repeated. However, a citation to the structure in the earlier work coverage of the literature to the end of 2012. General aspects is indicated by its number with a prefix (i.e., 1/x refers to such as theory of the MALDI process, matrices, derivatization, structure x in the first review and 2/x to structure x the second). MALDI imaging, and fragmentation are covered in the first part Books, general reviews, and review-type articles directly of the review and applications to various structural types concerned with, or including, MALDI analysis of carbohydrates constitute the remainder. The main groups of compound are and glycoconjugates to have been published during the review oligo- and poly-saccharides, glycoproteins, glycolipids, glyco- period are listed in Table 1. Reviews relating to more specific sides, and biopharmaceuticals. Much of this material is presented aspects of MALDI analysis are listed in the appropriate sections. in tabular form. Also discussed are medical and industrial applications of the technique, studies of enzyme reactions, and II.
    [Show full text]
  • United States Patent (19) 11 Patent Number: 5,981,835 Austin-Phillips Et Al
    USOO598.1835A United States Patent (19) 11 Patent Number: 5,981,835 Austin-Phillips et al. (45) Date of Patent: Nov. 9, 1999 54) TRANSGENIC PLANTS AS AN Brown and Atanassov (1985), Role of genetic background in ALTERNATIVE SOURCE OF Somatic embryogenesis in Medicago. Plant Cell Tissue LIGNOCELLULOSC-DEGRADING Organ Culture 4:107-114. ENZYMES Carrer et al. (1993), Kanamycin resistance as a Selectable marker for plastid transformation in tobacco. Mol. Gen. 75 Inventors: Sandra Austin-Phillips; Richard R. Genet. 241:49-56. Burgess, both of Madison; Thomas L. Castillo et al. (1994), Rapid production of fertile transgenic German, Hollandale; Thomas plants of Rye. Bio/Technology 12:1366–1371. Ziegelhoffer, Madison, all of Wis. Comai et al. (1990), Novel and useful properties of a chimeric plant promoter combining CaMV 35S and MAS 73 Assignee: Wisconsin Alumni Research elements. Plant Mol. Biol. 15:373-381. Foundation, Madison, Wis. Coughlan, M.P. (1988), Staining Techniques for the Detec tion of the Individual Components of Cellulolytic Enzyme 21 Appl. No.: 08/883,495 Systems. Methods in Enzymology 160:135-144. de Castro Silva Filho et al. (1996), Mitochondrial and 22 Filed: Jun. 26, 1997 chloroplast targeting Sequences in tandem modify protein import specificity in plant organelles. Plant Mol. Biol. Related U.S. Application Data 30:769-78O. 60 Provisional application No. 60/028,718, Oct. 17, 1996. Divne et al. (1994), The three-dimensional crystal structure 51 Int. Cl. ............................. C12N 15/82; C12N 5/04; of the catalytic core of cellobiohydrolase I from Tricho AO1H 5/00 derma reesei. Science 265:524-528.
    [Show full text]
  • 次世代ポストゲノム・ANNUAL REPORT2011.Indd
    Frontier Research Center for Post-genome Science and Technology Faculty of Advanced Life Science Hokkaido University 2011 ANNUAL REPORT は じ め に Introduction ごあいさつ／Message from the Director 02 次世代ポストゲノムとは／What's the "Frontier p s t" 04 沿革／Chronology 05 研 究 活 動 Research Activities 次世代ポストゲノム研究概要／Highlights of the Frontier P S T 06 ・創薬科学基盤イノベーションハブ 08 Biomedical Science & Drug Discovery Hub ・ポストゲノムタンパク質解析イノベーションハブ 12 Protein Structure Hub ・フォトバイオイメージングイノベーションハブ 14 Bio-Imaging Hub ・バイオミクスイノベーションハブ 15 Biomics Hub ・基盤支援・産学連携部門 17 Division for Supporting Basic Science & Industrial Cooperation 研究セミナー／Seminar 19 研究プロジェクト／Project 22 研 究 業 績 Research Achievement ・創薬科学基盤イノベーションハブ 28 Biomedical Science & Drug Discovery Hub ・ポストゲノムタンパク質解析イノベーションハブ 34 Protein Structure Hub ・フォトバイオイメージングイノベーションハブ 37 Bio-Imaging Hub ・バイオミクスイノベーションハブ 39 Biomics Hub ・基盤支援・産学連携部門 41 Division for Supporting Basic Science & Industrial Cooperation H23年度に受入のあった資金 Sources of Research Funding For 2011 １）・外部資金／National Research Funding 48 ・受託研究等／Government Projects 48 ・民間等からの研究資金／Private Research Funding 51 ・寄付金受入／Donations 54 ２）科学研究費補助金／Grant-in-aid for Scientific Research 55 視察一覧・組織図／Visiting to Frontier-PST／Organization 60 構成員一覧／Staff List of Frontier-PST 61 ごあいさつ 北海道大学では、21世紀における大学の機構改革、特に大学院の組織改革とし て、学院・研究院制度が導入されつつあり、これまでの部局の壁を超えた新しい 生命科学の教育、研究をめざす融合型組織として、北海道大学大学院生命科学院 と、その研究の中核組織である北海道大学大学院先端生命科学研究院が、2006年 ４月から新しく発足し、次世代ポストゲノム研究センターは先端生命科学研究院 の中核的付属施設として同時に併設されました。６年経過した現在、大学の中期 目標設定の中で、センターでは、先端生命科学研究院における応用開発という面 も含めて、北大における生命科学研究における中核的機能を果たしながら世界的 な研究拠点を目指して研究を更に充実・発展させようとしています。
    [Show full text]
  • Are Glucosylceramide-Related Sphingolipids Involved in the Increased Risk for Cancer in Gaucher Disease Patients? Review and Hypotheses
    cancers Review Are Glucosylceramide-Related Sphingolipids Involved in the Increased Risk for Cancer in Gaucher Disease Patients? Review and Hypotheses 1,2, 1,3, 1 1,2 Patricia Dubot y , Leonardo Astudillo y, Nicole Therville , Frédérique Sabourdy , Jérôme Stirnemann 4 , Thierry Levade 1,2,* and Nathalie Andrieu-Abadie 1,* 1 INSERM UMR1037, CRCT (Cancer Research Center of Toulouse), and Université Paul Sabatier, 31037 Toulouse, France; [email protected] (P.D.); [email protected] (L.A.); [email protected] (N.T.); [email protected] (F.S.) 2 Laboratoire de Biochimie Métabolique, Centre de Référence en Maladies Héréditaires du Métabolisme, Institut Fédératif de Biologie, CHU de Toulouse, 31059 Toulouse, France 3 Service de Médecine Interne, CHU de Toulouse, 31059 Toulouse, France 4 Service de Médecine Interne Générale, Hôpitaux Universitaires de Genève, CH-1211 Geneva, Switzerland; [email protected] * Correspondence: [email protected] (T.L.); [email protected] (N.A.-A.) These authors contributed equally to this work. y Received: 28 November 2019; Accepted: 14 February 2020; Published: 18 February 2020 Abstract: The roles of ceramide and its catabolites, i.e., sphingosine and sphingosine 1-phosphate, in the development of malignancies and the response to anticancer regimens have been extensively described. Moreover, an abundant literature points to the effects of glucosylceramide synthase, the mammalian enzyme that converts ceramide to β-glucosylceramide, in protecting tumor cells from chemotherapy. Much less is known about the contribution of β-glucosylceramide and its breakdown products in cancer progression. In this chapter, we first review published and personal clinical observations that report on the increased risk of developing cancers in patients affected with Gaucher disease, an inborn disorder characterized by defective lysosomal degradation of β-glucosylceramide.
    [Show full text]
  • (10) Patent No.: US 8119385 B2
    US008119385B2 (12) United States Patent (10) Patent No.: US 8,119,385 B2 Mathur et al. (45) Date of Patent: Feb. 21, 2012 (54) NUCLEICACIDS AND PROTEINS AND (52) U.S. Cl. ........................................ 435/212:530/350 METHODS FOR MAKING AND USING THEMI (58) Field of Classification Search ........................ None (75) Inventors: Eric J. Mathur, San Diego, CA (US); See application file for complete search history. Cathy Chang, San Diego, CA (US) (56) References Cited (73) Assignee: BP Corporation North America Inc., Houston, TX (US) OTHER PUBLICATIONS c Mount, Bioinformatics, Cold Spring Harbor Press, Cold Spring Har (*) Notice: Subject to any disclaimer, the term of this bor New York, 2001, pp. 382-393.* patent is extended or adjusted under 35 Spencer et al., “Whole-Genome Sequence Variation among Multiple U.S.C. 154(b) by 689 days. Isolates of Pseudomonas aeruginosa” J. Bacteriol. (2003) 185: 1316 1325. (21) Appl. No.: 11/817,403 Database Sequence GenBank Accession No. BZ569932 Dec. 17. 1-1. 2002. (22) PCT Fled: Mar. 3, 2006 Omiecinski et al., “Epoxide Hydrolase-Polymorphism and role in (86). PCT No.: PCT/US2OO6/OOT642 toxicology” Toxicol. Lett. (2000) 1.12: 365-370. S371 (c)(1), * cited by examiner (2), (4) Date: May 7, 2008 Primary Examiner — James Martinell (87) PCT Pub. No.: WO2006/096527 (74) Attorney, Agent, or Firm — Kalim S. Fuzail PCT Pub. Date: Sep. 14, 2006 (57) ABSTRACT (65) Prior Publication Data The invention provides polypeptides, including enzymes, structural proteins and binding proteins, polynucleotides US 201O/OO11456A1 Jan. 14, 2010 encoding these polypeptides, and methods of making and using these polynucleotides and polypeptides.
    [Show full text]
  • Glucocerebrosidase Mutations and Synucleinopathies. Potential Role of Sterylglucosides and Relevance of Studying Both GBA1 and GBA2 Genes
    MINI REVIEW published: 28 June 2018 doi: 10.3389/fnana.2018.00052 Glucocerebrosidase Mutations and Synucleinopathies. Potential Role of Sterylglucosides and Relevance of Studying Both GBA1 and GBA2 Genes Rafael Franco 1,2*†, Juan A. Sánchez-Arias 3†, Gemma Navarro 1,2,4 and José L. Lanciego 2,3,5* 1Department of Biochemistry and Molecular Biomedicine, School of Biology, University of Barcelona, Barcelona, Spain, 2Centro de Investigación Biomédica en Red de Enfermedades Neurodegenerativas (CiberNed), Instituto de Salud Carlos III, Madrid, Spain, 3Department of Neuroscience, Centro de Investigación Médica Aplicada (CIMA), University of Navarra, Pamplona, Spain, 4Department of Biochemistry and Physiology, School of Pharmacy, University of Barcelona, Barcelona, Spain, 5Department of Neuroscience, Instituto de Investigación Sanitaria de Navarra (IdiSNA), Pamplona, Spain Gaucher’s disease (GD) is the most prevalent lysosomal storage disorder. GD is caused Edited by: by homozygous mutations of the GBA1 gene, which codes for beta-glucocerebrosidase Francesco Fornai, (GCase). Although GD primarily affects peripheral tissues, the presence of neurological Università degli Studi di Pisa, Italy symptoms has been reported in several GD subtypes. GBA1 mutations have Reviewed by: Rosario Moratalla, recently deserved increased attention upon the demonstration that both homo- and Consejo Superior de Investigaciones heterozygous GBA1 mutations represent the most important genetic risk factor for the Científicas (CSIC), Spain Fabrizio Michetti, appearance of synucleinopathies like Parkinson’s disease (PD) and dementia with Lewy Università Cattolica del Sacro Cuore, bodies (LBD). Although reduced GCase activity leads to alpha-synuclein aggregation, Italy the mechanisms sustaining a role for GCase in alpha-synuclein homeostasis still *Correspondence: Rafael Franco remain largely unknown.
    [Show full text]
  • ZHOU-THESIS-2018.Pdf (2.307Mb)
    PHYLOGENY AND PREDICTED FUNCTIONAL CAPABILITIES OF A SULFUR- OXIDIZING AND DENITRIFYING CLADE OF BACTEROIDETES FROM SULFIDIC ENVIRONMENTS A Thesis by KECEN ZHOU Submitted to the Office of Graduate and Professional Studies of Texas A&M University in partial fulfillment of the requirements for the degree of MASTER OF SCIENCE Chair of Committee, Jason B. Sylvan Co-Chair of Committee, Lisa Campbell Committee Member, Brendan E. Roark Head of Department, Shari Yvon-Lewis August 2018 Major Subject: Oceanography Copyright 2018 Kecen Zhou ABSTRACT Environments rich in sulfur compounds (sulfidic) are common in the ocean, and the ability to gain energy (dissimilatory) from sulfur redox reactions is widespread in bacteria. The Sulfiphilic Bacteroidetes (SB), have been found exclusively in sulfidic environments, but little is known about their metabolic potential and membership. The ability to perform dissimilatory sulfur redox would make them unique among Bacteroidetes, which are primarily known as heterotrophs that specialize in degrading complex organic molecules. Using 16S rRNA phylogeny and analysis of single amplified genomes (SAGs) from Saanich Inlet, a seasonally hypoxic basin, we elucidate the global distribution and potential metabolic capabilities of the SB clade. Phylogenetic analysis revealed that this clade was monophyletic and had a global distribution. It is hypothesized this clade combines heterotrophic amino acid and sugar uptake with denitrification and respiratory sulfur oxidation/polysulfide reduction. Putative genes for sulfur oxidation via polysulfide reductase (psr) were found in the combined genome, and phylogenetic analysis confirmed these genes were likely to be psrABC. A denitrification pathway was present and complete save for the absence of a gene catalyzing reduction of NO to N2O.
    [Show full text]
  • Isolation and Characterization of Cellulase-Producing Microorganisms in The
    Isolation and Characterization of Cellulase-Producing Microorganisms in the Red Sea Dissertation by Siham Kamal Fatani In Partial Fulfillment of the Requirements for the Degree of Doctor of Philosophy King Abdullah University of Science and Technology, Thuwal, Kingdom of Saudi Arabia September, 2019 2 Examination Committee Page The Dissertation of Siham Fatani is Examined by the Committee Members Committee Chairperson: Prof. Takashi Gojobori Committee Members: Prof. Vladimir Bajic, Prof. Susana Agusti, Prof. Shugo Watabe 3 © September, 2019 Siham Kamal Fatani All Rights Reserved 4 ACKNOWLEDGMENTS This work is a consequence of great help and guidance from many people; faculty, family and friends. I am really happy to have these people by my side while undertaking my PhD Dissertation. First, I would like to express my profound gratitude and respect to my supervisor, Prof. Takashi Gojobori, Distinguished Professor of Bioscience and Associate Director of Computational Bioscience Research Center for his professional guidance, and regular encouragement and motivation at various stages of this work. I would also like to thank Dr. Katsuhiko Mineta for his support and advice during my research. Moreover, I would like to express my deepest appreciation to Dr. Yoshimoto Saito for his assistance and suggestions throughout my project. I also appreciate Mr. Mohammad Al-Arawi for his support and technical advice and without them this work would not have been possible for me to complete. In addition, I would like to thank my committee members, Prof. Vladimir Bajic, Prof. Susana Agusti and Prof. Shugo Watabe for giving their time to review my Ph.D. thesis and for offering their insight and suggestions.
    [Show full text]
  • Supplemental Table 7. Every Significant Association
    Supplemental Table 7. Every significant association between an individual covariate and functional group (assigned to the KO level) as determined by CPGLM regression analysis. Variable Unit RelationshipLabel See also CBCL Aggressive Behavior K05914 + CBCL Emotionally Reactive K05914 + CBCL Externalizing Behavior K05914 + K15665 K15658 CBCL Total K05914 + K15660 K16130 KO: E1.13.12.7; photinus-luciferin 4-monooxygenase (ATP-hydrolysing) [EC:1.13.12.7] :: PFAMS: AMP-binding enzyme; CBQ Inhibitory Control K05914 - K12239 K16120 Condensation domain; Methyltransferase domain; Thioesterase domain; AMP-binding enzyme C-terminal domain LEC Family Separation/Social Services K05914 + K16129 K16416 LEC Poverty Related Events K05914 + K16124 LEC Total K05914 + LEC Turmoil K05914 + CBCL Aggressive Behavior K15665 + CBCL Anxious Depressed K15665 + CBCL Emotionally Reactive K15665 + K05914 K15658 CBCL Externalizing Behavior K15665 + K15660 K16130 KO: K15665, ppsB, fenD; fengycin family lipopeptide synthetase B :: PFAMS: Condensation domain; AMP-binding enzyme; CBCL Total K15665 + K12239 K16120 Phosphopantetheine attachment site; AMP-binding enzyme C-terminal domain; Transferase family CBQ Inhibitory Control K15665 - K16129 K16416 LEC Poverty Related Events K15665 + K16124 LEC Total K15665 + LEC Turmoil K15665 + CBCL Aggressive Behavior K11903 + CBCL Anxiety Problems K11903 + CBCL Anxious Depressed K11903 + CBCL Depressive Problems K11903 + LEC Turmoil K11903 + MODS: Type VI secretion system K01220 K01058 CBCL Anxiety Problems K11906 + CBCL Depressive
    [Show full text]
  • Suplementary Material To: Draft Genome of Thermomonospora Sp. CIT 1 (Thermomonosporaceae) and in Silico Evidence of Its Function
    1 Genetics and Molecular Biology Suplementary material to: Draft genome of Thermomonospora sp. CIT 1 (Thermomonosporaceae) and in silico evidence of its functional role in filter cake biomass deconstruction Table S4 - Identifications of enzymes with activity on carbohydrate structures present in the circular genome of Thermomonospora curvata DSM 43183 (Thermomonosporaceae). Predictions were performed with dbCAN online, following for blastp confirmation against the non-redundant NCBI protein database of the occurrence of predicted protein-like sequence deposition. Search results for dbCAN conserved domains BLASTP RESULTS ORF CAZy QUERY IDENTIT LENGTH ID CAZy ENZYME NAME (NCBI) E-VALUE ACCESSION FAMILY COVER Y mycofactocin system GMC family 517 AA3.hmm glucose-methanol-choline (GMC) 100 0.00E+00 100 WP_012852714 oxidoreductase MftG 528 AA4.hmm vanillyl-alcohol oxidase (EC 1.1.3.38) FAD-binding oxidoreductase 99 0.00E+00 76 WP_067912508 NAD(P)H dehydrogenase 209 AA6.hmm 1,4-benzoquinone reductase (EC. 1.6.5.6) 99 4.00E-128 88 SEG76937 (quinone) NAD(P)H-dependent FMN 186 AA6.hmm 1,4-benzoquinone reductase (EC. 1.6.5.6) 100 2.00E-84 70 SEG82383 reductase glycolate oxidase FAD binding 411 AA7.hmm glycolate oxidase (EC 1.1.3.15) 98 0.00E+00 77 SEG60993 subunit 482 AA7.hmm glycolate oxidase (EC 1.1.3.15) glycolate oxidase 100 0.00E+00 88 SEG60983 459 AA7.hmm 1- FAD-binding oxidoreductase 99 0.00E+00 72 WP_091378734 lytic polysaccharide monooxygenases 212 AA10.hmm chitin-binding protein 100 7.00E-86 73 WP_079318887 (LPMOs) 505 CBM35.hmm CBM35
    [Show full text]
  • Ambroxol Improves Lysosomal Biochemistry in Glucocerebrosidase Mutation-Linked Parkinson Disease Cells
    doi:10.1093/brain/awu020 Brain 2014: 137; 1481–1495 | 1481 BRAIN A JOURNAL OF NEUROLOGY Ambroxol improves lysosomal biochemistry in glucocerebrosidase mutation-linked Parkinson disease cells Alisdair McNeill,1 Joana Magalhaes,1 Chengguo Shen,2 Kai-Yin Chau,1 Derralyn Hughes,3 3 4 1 5 1 Atul Mehta, Tom Foltynie, J. Mark Cooper, Andrey Y. Abramov, Matthew Gegg and Downloaded from Anthony H.V. Schapira1 1 Department of Clinical Neurosciences, Institute of Neurology, University College London, UK 2 Bioinformatics Unit, Source Bioscience, Nottingham, UK 3 Lysosomal storage disorders unit, Royal Free Hospital, London, UK http://brain.oxfordjournals.org/ 4 Sobell Department of Motor Neuroscience and Movement Disorders, Institute of Neurology, University College London, UK 5 Department of Molecular Neuroscience, Institute of Neurology, University College London, UK Correspondence to: Professor A.H.V. Schapira, Chairman and Head of Department, Department of Clinical Neurosciences, UCL Institute of Neurology, Upper level 3, UCL Medical School, Royal Free Hospital London NW3 2PF UK at UCL Library Services on June 27, 2014 E-mail: [email protected] Gaucher disease is caused by mutations in the glucocerebrosidase gene, which encodes the lysosomal hydrolase glucosylcer- amidase. Patients with Gaucher disease and heterozygous glucocerebrosidase mutation carriers are at increased risk of develop- ing Parkinson’s disease. Indeed, glucocerebrosidase mutations are the most frequent risk factor for Parkinson’s disease in the general population. Therefore there is an urgent need to understand the mechanisms by which glucocerebrosidase mutations predispose to neurodegeneration to facilitate development of novel treatments. To study this we generated fibroblast lines from skin biopsies of five patients with Gaucher disease and six heterozygous glucocerebrosidase mutation carriers with and without Parkinson’s disease.
    [Show full text]